Chronic lymphocytic leukemia (CLL) can rarely be cured. Still, most people live with the disease for many years. Some people with CLL can live for years without treatment, but over time, most will need to be treated. Most people with CLL are treated on and off for years.
Acute myeloid leukemia (AML) is the most fatal type of leukemia. The five-year survival rate (how many people will be alive five years after diagnosis) for AML is 29.5%. Leukemia is a cancer that usually affects white blood cells, though it can start in other types of blood cells.
The slow-growing form of chronic lymphocytic leukemia (CLL) is the least serious type of leukemia. It is a disease of older people; the average age at diagnosis is around 71. CLL is a malignancy of mature lymphocytes, which usually grow and divide slowly, resulting in a slowly progressive disease.
Acute myeloid leukemia (AML)
The most common form of acute (fast-developing) leukemia among adults , AML is also the most critical because it progresses rapidly.
In general, about 80% to 90% of adults will have complete remissions at some point during these treatments. This means leukemia cells can no longer be seen in their bone marrow. Unfortunately, about half of these patients relapse, so the overall cure rate is in the range of 40%.
Around 20 out of 100 (around 20 percent) will survive their leukemia for five years or more after diagnosis. Your age affects how well leukemia responds to treatment. Younger people have a better prognosis.
Acute myeloid leukaemia (AML) is an aggressive condition that develops rapidly, so treatment will usually begin a few days after a diagnosis has been confirmed.
Key points – emergencies in leukemia
The high risk of bleeding in uncontrolled acute promyelocytic leukemia (APML) represents a medical emergency. To prevent coagulopathy, anti-leukemic therapy should be initiated as soon as possible alongside meticulous supportive care.
AML Outlook. People with ALL often have a better prognosis (outlook) than people with AML do. About 69 percent of people with ALL live at least five years after diagnosis, whereas about 29 percent of people with AML live at least five years after diagnosis.
Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. The term "chronic" in chronic lymphocytic leukemia comes from the fact that this leukemia typically progresses more slowly than other types of leukemia.
Chronic leukemia involves more-mature blood cells. These blood cells replicate or accumulate more slowly and can function normally for a period of time. Some forms of chronic leukemia initially produce no early symptoms and can go unnoticed or undiagnosed for years.
Chronic leukemia inhibits the development of blood stem cells, ultimately causing them to function less effectively than healthy mature blood cells. As compared to acute leukemia, chronic leukemia tends to be less severe and progresses more slowly.
Acute lymphocytic leukemia (ALL) 5-year survival rate is 68.8%. Chronic myeloid leukemia (CML) 5-year survival rate is 67.8%. Acute myeloid leukemia (AML) 5-year survival rate is 27.6%. Acute monocytic leukemia (AML-M5) 5-year survival rate is 23.7%.
Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. It is the most common type of acute leukemia in adults.
Prognosis and Prognostic Factors
More than 25% of adults with AML (about 45% of those who attain CR) can be expected to survive 3 or more years and may be cured.
The case report suggests that underlying acute myeloid leukemia should be included in the differential diagnosis of sudden death with multisystem organ failure, however rare. Actually, it represents a quite unusual cause of sudden death, rarely reported in the medicolegal literature.
Patients will often need to stay in the hospital for 3 to 4 weeks during treatment. However, depending on the situation, many patients can leave the hospital. Those who do, usually need to visit the doctor regularly during treatment.
Someone who has leukemia may die from different things. There may be a sudden loss of blood or a stroke, because of the inability of the blood to clot. There may be complications from low hemoglobin levels. Infection is possible.
Chronic leukemia usually gets worse slowly, over months to years, while acute leukemia develops quickly and progresses over days to weeks. The two main types of leukemia can be further organized into groups that are based on the type of white blood cell that is affected — lymphoid or myeloid.
The 5-year survival rate for people 20 and older with AML is 27%. For people younger than 20, the survival rate is 69%. However, survival depends on several factors, including biologic features of the disease and, in particular, a patient's age (see Subtypes for more information).
The 5-year survival rate for people age 20 and older is 40%. The 5-year survival rate for people under age 20 is 89%. Recent advances in treatment have significantly lengthened the lives of people with ALL. However, survival rates depend on several factors, including biologic features of the disease and a person's age.
There are different types of leukemia which can be grouped into acute leukemias and chronic leukemias, and it's a complete myth that leukemia is incurable. Thanks to advancements in treatment such as better chemotherapy and transplant regimens, many patients can be cured of their disease.
Leukemia staging is generally determined by blood cell counts and the accumulation of leukemia cells within organs. When diagnosing leukemia, the test most commonly performed is a complete blood count (CBC), which measures: White blood cell count. Red blood cell count.